Alternatively spliced, truncated human BRCA2 isoforms contain a novel coding exon

European Journal of Human Genetics

Volumn 11, Issue 12, 2003, Pages 951-954

  Speevak, Marsha D ^a,b   Young, Sean S ^a,c   Feilotter, Harriet ^d   Ainsworth, Peter ^e  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CREDIT VALLEY HOSPITAL   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

^e VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Alternative splicing; BRCA2; PTT; Tumour suppressor gene

Indexed keywords

BRCA2 PROTEIN; COMPLEMENTARY DNA; GENOMIC DNA; ISOPROTEIN; RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSCRIPTION; GERM LINE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKOCYTE; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION;

ALTERNATIVE SPLICING; BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; EXONS; GENES, BRCA2; GERM-LINE MUTATION; HUMANS;

EID: 0347287031     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201063     Document Type: Article

References (18)

1. Wooster R, Bignell G, Lancaster J et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-792.
2. Collins N, McManus R, Wooster R et al: Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 1995; 10: 1673-1675.
3. Gudmundsson J, Johannesdottir G, Bergthorsson JT et al: Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res 1995; 55: 4830-4832.
4. Wong AKC, Pero R, Ormonde PA, Tavtigian SV, Bartel PL: RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 1997; 272: 31941-31944.
5. Marmorstein LY, Ouchi T, Aaronson SA: The BRCA2 gene product functionally interacts with p53 and RAD51. Proc Natl Acad Sci USA 1998; 95: 13869-13874.
6. Zou JF, Yoshinbu H, Siddique H, Rao VN, Reddy ESP: Structure and expression of variant BRCA2a lacking the transactivation domain. Oncol Rep 1999; 6: 437-440.
7. Bieche I, Lidereau R: Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue. Cancer Res 1999; 59: 2546-2550.
8. Hunt S: Human DNA sequence from clone RP1-214K23 on chromosome 13, containing BRCA2 gene. NCBI Entrez database 2001; gi 929047 emb Z74739.1 HS214K23 [1929047].
9. Garvin AM: A complete protein truncation test for BRCA1 and BRCA2. Eur J Hum Genet 1998; 6: 226-234.
10. Connor F, Bertwistle D, Mee PJ et al: Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat Genet 1997; 17: 423-430.
11. Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM: BRCA2 is cytoplasmic: implications for cancer-linked mutations. Proc Natl Acad Sci USA 1999; 96: 13920-13925.
12. Yano K, Morotomi K, Saito H, Kato M, Matsuo F, Mini Y: Nuclear localization signals of the BRCA2 protein. Biochem Biophys Res Commun 2000; 270: 171-175.
13. Murtif-Park V, Kenwright KA, Surtevant DB, Karman Pivnick E: Alternative splicing of exons 29 and 30 in the neurofibromatosis type 1 gene. Hum Genet 1998; 103: 382-385.
14. Wimmer K, Eckart M, Rehder H, Fonatsch C: Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients. Hum Genet 2000; 106: 311-313.
15. Thomson SA, Wallace MR: RT-PCR splicing analysis of the NF1 open reading frame. Hum Genet 2002; 110: 495-502.
16. Flaman JM, Waridel F, Estreicher A et al: The human tumor suppressor gene p53 is alternatively spliced in normal cells. Oncogene 1996; 12: 813-818.
17. Sulekova Z, Reina-Sanchez J, Ballhausen WG: Multiple APC messenger RNA isoforms encoding exon 15 short open reading frames are expressed in the context of a novel exon 10A-derived sequence. Int J Cancer 1995; 63: 435-441.
18. Stoilov P, Meshorer E, Gencheva M, Glick D, Soreq H, Stamm S: Defects in pre-mRNA processing as causes of and predisposition to diseases. DNA Cell Biol 2002; 21: 803-818.